Cite Filings / LRMR / 0001193125-26-462242
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Larimar Therapeutics, Inc. · Filed 2026-11-16 · Acc 0001193125-26-462242

Documents 1

  • 10-Q Quarterly Report , lrmr-20260930.htm

Around this filing

  • 2026-11-18 4 Chief Medical Officer bought 3,322 shares at $3.01 ($9,999)
  • 2026-11-16 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-11-16 4 Director bought 3,289.47 shares at $3.06 ($10,058)
  • 2026-11-16 S-8 Securities Offered to Employees in Benefit Plans
  • 2026-11-16 10-Q Quarterly Report
  • 2026-11-16 8-K Results of operations
  • 2026-08-04 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading lrmr-20260930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…